Author Nierhaus, Axel

1 to 9 of 9 Items
  • 2012 | Journal Article
    ​ ​Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis A Randomized Trial​
    Brunkhorst, F. M.; Oppert, M.; Marx, G.; Bloos, F.; Ludewig, K.; Putensen, C. & Nierhaus, A. et al.​ (2012) 
    JAMA, 307(22) pp. 2390​-2399​.​ DOI: https://doi.org/10.1001/jama.2012.5833 
    ​Details  DOI  PMID  PMC  WoS 
  • 2015 | Journal Article | 
    ​ ​The use of extracorporeal carbon dioxide removal to avoid intubation in patients failing non-invasive ventilation – a cost analysis​
    Braune, S.; Burchardi, H.; Engel, M.; Nierhaus, A.; Ebelt, H.; Metschke, M. & Rosseau, S. et al.​ (2015) 
    BMC Anesthesiology, 15(1) art. 160​.​ DOI: https://doi.org/10.1186/s12871-015-0139-0 
    ​Details  DOI  PMID  PMC 
  • 2016 | Journal Article
    ​ ​Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock A Randomized Clinical Trial​
    Bloos, F.; Trips, E.; Nierhaus, A.; Briegel, J.; Heyland, D. K.; Jaschinski, U. & Moerer, O. et al.​ (2016) 
    JAMA Internal Medicine, 176(9) pp. 1266​-1276​.​ DOI: https://doi.org/10.1001/jamainternmed.2016.2514 
    ​Details  DOI  PMID  PMC  WoS 
  • 2018 | Journal Article | 
    ​ ​Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival​
    Winkler, M. S; Nierhaus, A.; Rösler, G.; Lezius, S.; Harlandt, O.; Schwedhelm, E. & Böger, R. H et al.​ (2018) 
    Critical Care, 22(1) art. 216​.​ DOI: https://doi.org/10.1186/s13054-018-2090-1 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial​
    Elke, G.; Bloos, F.; Wilson, D. C.; Brunkhorst, F. M.; Briegel, J.; Reinhart, K. & Loeffler, M. et al.​ (2018) 
    Critical Care, 22(1).​ DOI: https://doi.org/10.1186/s13054-018-2001-5 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)​
    Winkler, M. S.; Märtz, K. B.; Nierhaus, A.; Daum, G.; Schwedhelm, E.; Kluge, S. & Gräler, M. H.​ (2019) 
    Journal of Intensive Care, 7(1) art. 23​.​ DOI: https://doi.org/10.1186/s40560-019-0376-2 
    ​Details  DOI  PMID  PMC 
  • 2020 | Journal Article
    ​ ​S1P lyase inhibition protects against sepsis by promoting disease tolerance via the S1P/S1PR3 axis​
    Weigel, C.; Hüttner, S. S.; Ludwig, K.; Krieg, N.; Hofmann, S.; Schröder, N. H. & Robbe, L. et al.​ (2020) 
    EBioMedicine, 58 pp. 102898​.​ DOI: https://doi.org/10.1016/j.ebiom.2020.102898 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Randomized controlled multicentre study of albumin replacement therapy in septic shock (ARISS): protocol for a randomized controlled trial​
    Sakr, Y.; Bauer, M.; Nierhaus, A.; Kluge, S.; Schumacher, U.; Putensen, C. & Fichtner, F. et al.​ (2020) 
    Trials, 21(1).​ DOI: https://doi.org/10.1186/s13063-020-04921-y 
    ​Details  DOI 
  • 2021 | Journal Article | 
    ​ ​Dynamics of Vascular Protective and Immune Supportive Sphingosine-1-Phosphate During Cardiac Surgery​
    Greiwe, G.; Moritz, E.; Amschler, K.; Poppe, A.; Sarwari, H.; Nierhaus, A. & Kluge, S. et al.​ (2021) 
    Frontiers in Immunology, 12.​ DOI: https://doi.org/10.3389/fimmu.2021.761475 
    ​Details  DOI 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100